← All companies

SPTX

Seaport Therapeutics, Inc.

SPTX Nasdaq Pharmaceutical Preparations EDGAR ↗

$20.65

+0.33 +1.62%

Key statistics

from XBRL data in SEC filings

Market cap

$1.11B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$64.2M

Total assets

$442M

Gross margin

—

52-week range

$14.85 – $23.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Results of operations (earnings release) Aug 3, 2026 10-Q Quarter ended 2026-03-31 Jun 8, 2026 8-K Results of operations (earnings release) Jun 8, 2026 8-K Amended charter or bylaws May 4, 2026

Other filings

4 Jun 24, 2026 SCHEDULE 13D May 11, 2026 SCHEDULE 13G May 11, 2026 3 OWNERSHIP DOCUMENT May 6, 2026 3 OWNERSHIP DOCUMENT May 6, 2026 4 May 6, 2026 SCHEDULE 13D May 6, 2026 4 May 4, 2026 4 May 4, 2026 4 May 4, 2026 4 May 4, 2026 4 May 4, 2026 4 May 4, 2026 4 May 4, 2026 4 May 4, 2026 4 May 4, 2026 4 May 4, 2026 4 May 4, 2026 4 May 4, 2026 4 May 4, 2026 S-8 May 4, 2026 424B4 May 1, 2026 EFFECT Apr 30, 2026 3 Apr 30, 2026 3 Apr 30, 2026 3 Apr 30, 2026 3 Apr 30, 2026 3 Apr 30, 2026 3 Apr 30, 2026 3 Apr 30, 2026 3 Apr 30, 2026 3 Apr 30, 2026 3 Apr 30, 2026 3 Apr 30, 2026 3 Apr 30, 2026